# Evaluation Interpretation

Audience: scientists, reviewers, operators, and release owners interpreting
benchmark reports, golden workflow results, prospective validation demos, and
validation package outputs.

## Interpretation Boundaries

Evaluation artifacts validate software behavior, workflow quality, guardrails,
and release readiness. They are not clinical validation, regulatory approval,
biomedical proof, assay results, dosing guidance, patient treatment guidance,
lab protocols, or synthesis instructions.

## Checklist

- Confirm report source and artifact hash.
- Confirm whether data is synthetic, mocked, retrospective, or prospective demo.
- Confirm guardrail results and known limitations.
- Separate evaluation outputs from evidence and review decisions.
- Include evaluation reports in validation packages only after redaction.

## Exercise: Synthetic Benchmark Report

Synthetic data:

- Report: `synthetic_guardrail_benchmark.json`
- Golden workflow: `enterprise_golden_demo.json`
- Validation package: `validation_package_demo/`
- Limitation: `mocked sources only`

Steps:

1. Open the benchmark report.
2. Identify dataset type and limitations.
3. Confirm no molecule activity/safety/efficacy conclusion is present.
4. Attach report to validation package.
5. Record a release-readiness interpretation.

Expected outcomes:

- Report is interpreted as software/process evidence.
- Known limitations are preserved.
- No clinical, biomedical, or molecule overclaim is made.

## Common Mistakes

- Calling a benchmark result proof of scientific validity.
- Omitting mocked or synthetic data labels.
- Treating prospective validation demos as clinical validation.
- Including secrets or raw unapproved data in validation packages.
